What is the difference between Nitrofurantoin and Macrobid (Nitrofurantoin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin vs. Macrobid: Understanding the Difference

Macrobid is a brand name for nitrofurantoin monohydrate/macrocrystals, which is a specific formulation of nitrofurantoin. 1, 2

Formulation Differences

  • Nitrofurantoin is available in different formulations: macrocrystals (Macrodantin), monohydrate, and monohydrate/macrocrystals (Macrobid) 1
  • Macrobid specifically contains the monohydrate/macrocrystals formulation of nitrofurantoin, which provides both immediate and sustained release of the medication 1, 3
  • The macrocrystal formulation allows for better absorption and potentially fewer gastrointestinal side effects compared to older nitrofurantoin formulations 4

Dosing Considerations

  • Macrobid (nitrofurantoin monohydrate/macrocrystals) is typically dosed at 100 mg twice daily for 5-7 days for uncomplicated UTIs 1
  • Other nitrofurantoin formulations may have different dosing regimens:
    • Nitrofurantoin macrocrystals can be dosed at 50-100 mg four times daily for 5 days 1
    • Nitrofurantoin macrocrystals prolonged release can be dosed at 100 mg twice daily for 5 days 1

Clinical Applications

  • Both Macrobid and other nitrofurantoin formulations are recommended as first-line treatments for uncomplicated urinary tract infections by major guidelines 1, 3
  • Clinical cure rates with nitrofurantoin (including Macrobid) range from 88-93% for uncomplicated UTIs 1
  • Bacterial cure rates range from 81-92% for uncomplicated UTIs 1

Antimicrobial Properties

  • All nitrofurantoin formulations, including Macrobid, are broad-spectrum antibiotics effective against many gram-positive and gram-negative urinary pathogens 4, 5
  • Nitrofurantoin has multiple mechanisms of action that may help prevent the development of resistance, which is why it has maintained effectiveness despite decades of use 6
  • Both formulations are particularly valuable in the era of increasing antimicrobial resistance 4, 5

Important Precautions

  • All nitrofurantoin formulations, including Macrobid, are contraindicated in patients with creatinine clearance <60 mL/min due to inadequate urinary drug concentrations and increased risk of toxicity 3
  • Both can cause acute pulmonary reactions ranging from mild dyspnea to noncardiogenic pulmonary edema in some patients 7
  • Common side effects for all nitrofurantoin formulations include nausea and headache 1

Clinical Decision Making

  • When prescribing for uncomplicated UTIs, Macrobid (nitrofurantoin monohydrate/macrocrystals) at 100 mg twice daily for 5 days is the preferred formulation according to the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases 1, 3
  • For patients who cannot tolerate twice-daily dosing or who might benefit from a different release profile, other nitrofurantoin formulations may be considered 1

In summary, the main difference is that Macrobid is a specific brand name for the nitrofurantoin monohydrate/macrocrystals formulation, which offers a dual-release mechanism that may provide advantages in terms of dosing convenience and tolerability compared to other nitrofurantoin formulations.

References

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Dosing Considerations in Adults with UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute pulmonary toxicity to nitrofurantoin.

The Journal of emergency medicine, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.